Microbial Identification Methods Market Report 2026

The microbial identification methods market size has grown strongly in recent years. It will grow from $5.49 billion in 2025 to $5.91 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing infectious disease outbreaks, reliance on culture-based identification, growth in food safety testing, regulatory focus on contamination control, expansion of clinical diagnostic microbiology.

The microbial identification methods market size is expected to see strong growth in the next few years. It will grow to $7.67 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising adoption of genomic sequencing tests, demand for automation in identification workflows, growth of rapid microbial testing technologies, increasing integration of digital lab infrastructure, rising investments in precision microbiology. Major trends in the forecast period include genomic sequencing integration in microbial identification, cloud-based microbial data analytics, AI-assisted microbial classification, automated identification platforms in industrial labs, iot-enabled contamination monitoring solutions.

The rising prevalence of infectious diseases is expected to drive the growth of the microbial identification methods market in the coming years. Infectious diseases are caused by harmful agents (pathogens) entering the body, including viruses, bacteria, fungi, and parasites. Major infectious diseases include HIV/AIDS (human immunodeficiency virus/acquired immunodeficiency syndrome), tuberculosis, malaria, and others. The growing prevalence of infectious diseases is influenced by factors such as antimicrobial resistance, climate change, and population growth. Microbial identification methods play a critical role in diagnosing, treating, and preventing infectious diseases by providing detailed information about the pathogens responsible for an infection, allowing healthcare professionals to make informed decisions regarding patient care. For example, in January 2023, a report published by the Government of Canada, a Canada-based federal authority, stated that 135 rabies samples were submitted in October 2022 and 159 samples in November 2022. Consequently, the rising prevalence of infectious diseases fuels the growth of the microbial identification methods market.

Major companies operating in the microbial identification methods market are concentrating on developing innovative solutions, such as mycobacteria and fungi IVD solutions, to reinforce their market presence. Mycobacteria and fungi in vitro diagnostic (IVD) solutions encompass a variety of products and technologies aimed at detecting, identifying, and characterizing mycobacterial and fungal pathogens in clinical samples. For example, in April 2023, Bruker Corporation, a US-based manufacturer of scientific instruments for molecular and materials research, introduced MALDI Biotyper IVD software, a new mycobacteria and fungi IVD solution. Key features include improved accuracy and speed in microbial identification through MALDI-TOF (matrix-assisted laser desorption/ionization-time of flight) mass spectrometry technology. This platform enables rapid identification of mycobacteria and fungi from cultured samples within minutes, greatly reducing the time compared to conventional methods. The new solutions also provide expanded databases and advanced software algorithms for enhanced specificity and sensitivity, allowing precise identification of a wider range of mycobacterial and fungal species.

In January 2023, Biolog Inc., a US-based biotechnology company, acquired MIDI Labs and MIDI, Inc. for an undisclosed sum. Through this acquisition, Biolog intends to strengthen its microbial identification and characterization capabilities by integrating MIDI’s advanced fatty acid methyl ester (FAME) analysis technology with its existing phenotype-based systems, offering a more comprehensive suite of diagnostic tools. MIDI Labs is a US-based innovator in microbial identification that provides contract laboratory services for microbial identification and enumeration.

Major companies operating in the microbial identification methods market are Merck KGaA, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, GE Healthcare, Avantor Inc., Eurofins Scientific SE, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., bioMerieux SA, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Beckman Coulter Inc., HiMedia Laboratories, Hardy Diagnostics, LuminUltra Technologies Ltd., Biolog Inc.

North America was the largest region in the microbial identification methods market in 2025. The regions covered in the microbial identification methods market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microbial identification methods market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs on laboratory reagents, sequencing kits, and analytical instruments have increased procurement costs in diagnostic and industrial microbiology laboratories, especially in North America and Europe where imports are heavily relied upon. These tariffs disrupt the availability of PCR reagents, culture media, and sequencing consumables, affecting test turnaround times. However, they have encouraged domestic production and technological innovation, leading to localized manufacturing of consumables and reducing dependency on foreign suppliers in the long term.

The microbial identification methods market research report is one of a series of new reports that provides microbial identification methods market statistics, including microbial identification methods industry global market size, regional shares, competitors with a microbial identification methods market share, detailed microbial identification methods market segments, market trends and opportunities, and any further data you may need to thrive in the microbial identification methods industry. This microbial identification methods market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Microbial identification methods are structured approaches and laboratory techniques used to determine the identity and characteristics of microorganisms by examining their phenotypic (observable traits) and genotypic (genetic) attributes. These methods play a vital role in diagnosing infectious diseases, ensuring food and water safety, investigating microbial ecology, and developing effective treatments or preventive strategies against pathogenic microorganisms.

The primary approaches in the microbial identification methods market include genotypic, phenotypic, and proteotypic techniques. Genotypic methods focus on identifying microorganisms based on their genetic composition, such as DNA or RNA sequences. These encompass bacterial identification systems, microbial enumeration systems, bacterial resistance identification systems, microbiology analyzers, and other types utilized by various end users, including pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, food testing laboratories, and other sectors.

The microbial identification methods market consists of revenues earned by entities by providing services such as fatty acid analysis, biochemical testing, antimicrobial susceptibility testing (AST), and mass spectrometry (MS). The market value includes the value of related goods sold by the service provider or included within the service offering. The microbial identification method market also includes sales of microbial identification systems, mass spectrometry instruments, sequencing platforms, culture media and kits, and antimicrobial susceptibility testing (AST) systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.